Beacon Roofing Supply Inc. is facing a hostile takeover bid from QXO Inc., which has proposed an all-cash tender offer valued at approximately $11 billion to acquire the company. Beacon's board previously rejected QXO's initial acquisition proposal as too low. In response to the hostile bid, Beacon has adopted a poison pill strategy, a defensive maneuver aimed at protecting shareholder interests. The poison pill allows existing shareholders to purchase additional shares at a discount, making it more difficult for QXO to gain control. QXO has reaffirmed its offer of $124.25 per share, despite Beacon's defensive measures. The situation has escalated, with Beacon's CEO Julian Francis discussing the ongoing negotiations and communications with QXO in various media appearances.
Beacon Roofing Supply Inc. adopted a poison pill strategy on Tuesday, designed to thwart the $11 billion hostile takeover bid launched by tech and software company QXO Inc. the previous day. https://t.co/ZpAdWkkUqX
Beacon adopts poison pill https://t.co/kiVFJ10UX0 https://t.co/2lUxOk6Czd
Beacon Roofing Supply has adopted a poison pill defense as the building products company pushes back against a hostile takeover approach from QXO https://t.co/38tBecGmQr